BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and production environments.
The acquisition strengthens BioPhorum’s Implementation Services offering and boosts the value the organisation brings to its customers and the wider industry in driving efficiency, transformation and improvement. Combining BioPhorum’s well-respected, collaborative best practice guidance with PharmaX’s deep implementation expertise enables delivery of practical, operational solutions at scale.
PharmaX Solutions specialises in the design, implementation, and integration of digital manufacturing systems, including MES, automation platforms, and quality systems, with deep expertise in GxP-regulated environments and IT/OT convergence. Adding PharmaX Solutions into the BioPhorum group of companies further expands the organisation’s international footprint across the sector. PharmaX Solutions operates with a team of 50 skilled professionals across four international offices located in Germany, Spain, Denmark, and Switzerland.
Through this acquisition, BioPhorum‘s core capabilities now provide a comprehensive end-to-end service spanning knowledge sharing, best practice guidance, training, and hands-on practitioner-led implementation.
Also Read: SGS Acquires Keystone Bioanalytical to Expand North America Drug Testing Capabilities
This strategic move is part of BioPhorum’s broader growth journey, deepening the value it provides to the Life Sciences industry. Over the past 18 months, BioPhorum has expanded its global portfolio by acquiring specialist training companies Brookwood Global, Compliance Hub and Inspired Pharma.
“We are delighted to welcome PharmaX Solutions into BioPhorum” said Deborah Kobewka, CEO of BioPhorum. “Our organisation is on an exciting growth trajectory, as demonstrated by our recent expansions in the training sector. Strengthening our Implementation Services offering with the addition of PharmaX perfectly complements this growth. Their deep expertise in digital manufacturing will directly benefit our customers and the wider life sciences community, helping them effectively embed our best practices to drive real, sustainable improvements in their operations, and ultimately accelerating the safe delivery of lifesaving medicines to patients.”
Karthik Kuncharam, Founder and CEO of PharmaX Solutions, commented: “We are delighted to be joining the BioPhorum group. Our team has always been dedicated to supporting pharmaceutical manufacturers in designing and implementing digital manufacturing systems that are both operationally effective and fully compliant with regulatory requirements. By combining our hands-on consulting experience with BioPhorum’s extensive network and industry-leading guidance, we are in a much stronger position to help global manufacturers optimise production and uphold the highest regulatory standards.”
Kunal Pandit, Partner at Five Arrows, the alternative assets arm of Rothschild & Co, an investor in BioPhorum, added: “BioPhorum’s acquisition of PharmaX Solutions marks a true milestone and a step-change in the capabilities of the organisation. As investors, we view this move as highly strategic, accelerating the evolution of BioPhorum’s business model from a Phorum-led entity to a broader, diversified platform. The ability to translate industry best practice insights into practical, operational execution for global manufacturers significantly expands its addressable market and long-term growth potential.”
SOURCE: PRNewswire
